Clinical Trial Update: Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating synthetic human parathyroid hormone 1-34 for treating hypoparathyroidism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Synthetic human parathyroid hormone 1-34 (parathyroid hormone 1-34)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Hypoparathyroidism | Phase 2 | Status: COMPLETED | Results posted: 2015-12-15